- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 513/12 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or in which the condensed system contains three hetero rings
Patent holdings for IPC class C07D 513/12
Total number of patents in this class: 38
10-year publication summary
|
1
|
1
|
1
|
0
|
2
|
1
|
3
|
2
|
4
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Wisconsin Alumni Research Foundation | 3894 |
4 |
| UCB Pharma S.A. | 248 |
3 |
| Glaxosmithkline Intellectual Property Development Limited | 762 |
2 |
| University of Florida Research Foundation, Inc. | 4035 |
2 |
| Ambit Biosciences Corporation | 61 |
2 |
| Shanghai Simr Biotechnology Co., Ltd | 24 |
2 |
| Shanghai Simrd Biotechnology Co., Ltd | 17 |
2 |
| Neusco Biotech Limited | 12 |
2 |
| F. Hoffmann-La Roche AG | 7947 |
1 |
| Hoffmann-La Roche Inc. | 3439 |
1 |
| Merck Sharp & Dohme Corp. | 2191 |
1 |
| Merck Patent GmbH | 5815 |
1 |
| Addex Pharma SA | 62 |
1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 703 |
1 |
| Dana-Farber Cancer Institute, Inc. | 2573 |
1 |
| Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | 331 |
1 |
| Irm LLC | 157 |
1 |
| Janssen Sciences Ireland UC | 183 |
1 |
| Katholieke Universiteit Leuven | 1194 |
1 |
| Oregon Health & Science University | 762 |
1 |
| Other owners | 7 |